Nasal-type NK/T cell lymphoma: Clinical features and treatment outcome

British Journal of Cancer

Volumn 92, Issue 7, 2005, Pages 1226-1230

  Lee, J ^a   Kim, W S ^a   Park, Y H ^b   Park, S H ^c   Park, K W ^a   Kang, J H ^a   Lee, S S ^b   Lee, S I ^d   Lee, S H ^a   Kim, K ^a   Jung, C W ^a   Ahn, Y C ^a   Ko, Y H ^a   Park, K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Dankook University   (South Korea)

Author keywords

Extra nasal; Natural killer cell lymphoma; Treatment

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IFOSFAMIDE; MESNA; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NATURAL KILLER CELL; NOSE CANCER; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; FEMALE; HEALTH STATUS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASAL CAVITY; NEOPLASM STAGING; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 18044390875     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602502     Document Type: Article

References (23)

1. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R (2004) CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 15: 1097-1108
2. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89: 4501-4513
3. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 17: 1244-1253
4. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54: 182 -190
5. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European - American classification of lymphoid neoplasm: a proposal from the International Lymphomas Study Group. Blood 84: 1361-1392
7. Hirakawa S, Kuyama M, Takahashi S, Yamasaki O, Kanzaki H, Teshima T, Harada M, Ma Y, Kawabata T, Yoshino T, Arata J (1999) Nasal and nasal-type natural killer/T-cell lymphoma. J Am Acad Dermatol 40: 268-272
8. Jaffe ES (1996) Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 87: 1207-1210
9. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis and epidemiology. Am J Surg Pathol 20: 103-111
10. Jaffe ES, Krenacs L, Kumar S, Kingma DW, Raffeld M (1999) Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 111(Suppl 1): S46-S55
11. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79: 2432-2437
12. Kim BS, Kim TY, Kim CW, Kim JY, Heo DS, Bang YJ, Kim NK (2003) Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy. Acta Oncol 42: 779-783
13. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, Hong WP, Park IY, Hahn JS, Roh JK, Kim BS (2000) Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 18: 54-63
14. Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY, Yoon SS, Lee HG, Kang WK, Lee HJ, Park CH, Park K (2001) CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12: 349-352
15. Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ (2004) NK and NK-like T-cell lymphoma in extranasal sites: a comparative cllinicopathological study according to site and EBV status. Histopathology 44: 1-10
16. Kobashi Y, Nakamura S, Sasajima Y, Koshikawa T, Yatabe Y, Kitoh K, Mori S, Ueda R, Yamabe H, Suchi T (1996) Inconsistent association of Epstein-Barr virus with CD56(NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology 28: 111-120
17. Lee KW, Kim DW, Im SA, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK (2004) Efficacy of ifosfamide, methotrexate, etoposide and prednisone (IMEP) chemotherapy in extranodal NK/T cell lymphoma, nasal type. Proc Am Soc Clin Oncol 22: 603s (abstr 6685a)
18. Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Choy D, Ho FC (1995) Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 13: 666-670
19. Mraz-Gernhard S, Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kim YH (2001) Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 19: 2179-2188
20. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E (1995) Clinicopathologic study of CD56 (NCAM) positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 19: 284-296
21. Obama K, Tara M, Niina K (2003) L-asparaginase-based induction therapy for advanced extranodal NK/T-cell lymphoma. Int J Hematol 78: 248-250
22. Peiper SC (1993) Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein - Barr virus in pathogenesis. Blood 82: 687-690
23. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC (1992) CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Hum Pathol 23: 798-804